GNbAC1

· GeNeuro Innovation SAS

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GNbAC1, covering 2020-10-20 to 2021-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of GNbAC1 in Multiple Sclerosis Patients [Phase 2]